loader
Please Wait
Applying Filters...
menu
    • menu

    Looking for Pharmaceutical Services offered by Recipharm AB? Find API & Drug Product Development for Formulation Development to address your drug delivery challenges on PharmaCompass.

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    Menu

    Recipharm AB

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 11Formulation Development

    filter clear-filterReset all filters

    PharmaCompass
    refreshReset Filter
    Learn More #LearnMore
    price-trend Ask Us

    01

    MINI-TABLET FORMULATION DEVELOPMENT

    MINI-TABLET FORMULATION DEVELOPMENT

    arrow
    Fi Europe 2024
    Not Confirmed

    02

    CAPSULE FORMULATION DEVELOPMENT

    CAPSULE FORMULATION DEVELOPMENT

    arrow
    Fi Europe 2024
    Not Confirmed

    03

    FORMULATION DEVELOPMENT OF GRANULES/PELL...

    FORMULATION DEVELOPMENT OF GRANULES/PELL...

    arrow
    Fi Europe 2024
    Not Confirmed

    04

    MODIFIED RELEASE FORMULATION DEVELOPMENT

    MODIFIED RELEASE FORMULATION DEVELOPMENT

    arrow
    Fi Europe 2024
    Not Confirmed

    05

    DRUG PRODUCT DEVELOPMENT

    DRUG PRODUCT DEVELOPMENT

    arrow
    Fi Europe 2024
    Not Confirmed

    06

    TECHNOLOGY TRANSFER SERVICES

    TECHNOLOGY TRANSFER SERVICES

    arrow
    Fi Europe 2024
    Not Confirmed

    07

    PARENTERAL FORMULATION DEVELOPMENT

    PARENTERAL FORMULATION DEVELOPMENT

    arrow
    Fi Europe 2024
    Not Confirmed

    08

    INHALATION FORMULATION DEVELOPMENT

    INHALATION FORMULATION DEVELOPMENT

    arrow
    Fi Europe 2024
    Not Confirmed

    09

    DEVELOPMENT OF SEMI-SOLID DOSAGE FORMS

    DEVELOPMENT OF SEMI-SOLID DOSAGE FORMS

    arrow
    Fi Europe 2024
    Not Confirmed

    10

    DEVELOPMENT OF TOPICAL DOSAGE FORMS

    DEVELOPMENT OF TOPICAL DOSAGE FORMS

    arrow
    Fi Europe 2024
    Not Confirmed

    11

    OPHTHALMIC FORMULATION DEVELOPMENT

    OPHTHALMIC FORMULATION DEVELOPMENT

    arrow
    Fi Europe 2024
    Not Confirmed